This event is archived. Final snapshot from when the story concluded. View on Dashboard
Business CEO appointment

ARCpoint appoints Peter Kendall Interim CEO

Analysis based on 6 articles · First reported Jun 09, 2026 · Last updated Jun 09, 2026

Sentiment
10
Attention
3
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The appointment of Peter Kendall as Interim CEO of ARCpoint Inc. is a significant leadership change that could positively impact the company's strategic direction and commercial development. Investors will closely watch the outcome of his 90-day assessment, which may lead to a clearer path for ARCpoint Inc.'s ARCpoint Labs platform and overall financial performance.

Healthcare Technology Biotechnology

ARCpoint Inc. announced the appointment of Peter Kendall as its Interim Chief Executive Officer, effective June 9, 2026. This appointment is subject to acceptance by the TSX Venture Exchange. In conjunction with this, Mark Constantine stepped down as President and CEO but will remain a director, focusing on sales, marketing, and commercial development of the ARCpoint Labs technology platform. Peter Kendall's initial 90-day mandate involves assessing ARCpoint Inc.'s business model, ARCpoint Labs platform, commercial relationships, assets, and strategic direction to provide recommendations for the company's future. ARCpoint Inc. has also agreed to grant 4,000,000 restricted share units to Peter Kendall, or to Driftwood Family Holdings, his wholly-owned company, with vesting scheduled for 12 months after the appointment date. The company and Driftwood Family Holdings will discuss a possible continuing engagement beyond the initial term.

priv
ARCpoint Inc. appointed Peter Kendall as Interim CEO, aiming to assess its business model and strategic direction. This change in leadership is expected to bring new perspectives and potentially improve the company's commercial and financial path forward.
Importance 100.0 Sentiment 10.0
per
Peter Kendall was appointed Interim CEO of ARCpoint Inc. and will lead the assessment of the company's business model and strategic direction for 90 days. His experience in healthcare commercialization and strategic partnerships is expected to benefit ARCpoint Inc..
Importance 90.0 Sentiment 20.0
priv
ARCpoint Labs is a technology platform owned and developed by ARCpoint Inc. for clinical lab services. Its commercial potential will be a key focus of Peter Kendall's assessment and Mark Constantine's ongoing efforts.
Importance 70.0 Sentiment 10.0
per
Mark Constantine stepped down as President and CEO of ARCpoint Inc. but will remain a director and focus on sales, marketing, and commercial development of the ARCpoint Labs technology platform. This transition allows him to concentrate on key growth areas for ARCpoint Inc..
Importance 60.0 Sentiment 0.0
exch
The TSX Venture Exchange's acceptance is required for Peter Kendall's appointment as Interim CEO of ARCpoint Inc. and the related RSU grants. Its regulatory oversight ensures compliance with exchange policies and securities laws.
Importance 40.0 Sentiment 0.0
priv
Driftwood Family Holdings, wholly-owned by Peter Kendall, will provide services to ARCpoint Inc. under the Interim CEO Agreement. It is also the potential recipient of RSUs or a non-continuance fee.
Importance 30.0 Sentiment 0.0
per
Adam Ho, CFO and director of ARCpoint Inc., commented on Peter Kendall's appointment, highlighting his alignment with the company's priorities. He remains a board member.
Importance 20.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.